Fingolimod: Difference between revisions
m (Protected "Fingolimod": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
Gerald Chi (talk | contribs) m (Changed protection level for "Fingolimod" ([Edit=Allow only autoconfirmed users] (expires 22:18, 28 August 2014 (UTC)) [Move=Allow only autoconfirmed users] (expires 22:18, 28 August 2014 (UTC)))) |
(No difference)
| |
Revision as of 22:18, 14 August 2014
Fingolimod (rINN, codenamed FTY720) is a novel immunosuppressant drug that causes lymphopenia by preventing egress of lymphocytes from lymph nodes. It is a sphingosine-1-phosphate receptor 1 modulator.
It is a chemical modification of the Myriocin (ISP-1) metabolite of the fungus Isaria sinclairii (Dong Chong Xia Cao). It is a structural analogue of sphingosine and gets phosphorylated by sphingosine kinases in the cell (most importantly sphingosine kinase 2).[1][2] The molecular biology of this biological function lies in FTY720's activity at one of the five sphingosine-1-phosphate receptors, S1P1.[3]] It is currently in phase III clinical trials as monotherapy for relapsing-remitting multiple sclerosis.[4] In a previous phase III trial of kidney transplantation, FTY720 was found to be no better than the existing standard of care.[citation needed]
See also
References
- ↑ Paugh SW, Payne SG, Barbour SE, Milstien S, Spiegel S (2003). "The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2". FEBS Lett. 554 (1–2): 189–93. PMID 14596938.
- ↑ Billich A, Bornancin F, Dévay P, Mechtcheriakova D, Urtz N, Baumruker T (2003). "Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases". J Biol Chem. 278 (48): 47408–15. doi:10.1074/jbc.M307687200. PMID 13129923. Free full text
- ↑ Hla T, Lee MJ, Ancellin N, Paik JH, Kluk MJ (2001). "Lysophospholipids--receptor revelations". Science. 294 (5548): 1875–8. doi:10.1126/science.1065323. PMID 11729304.
- ↑ Efficacy and Safety of Fingolimod in Patients With Relapsing-Remitting Multiple Sclerosis. ClinicalTrials.gov (2007-08-20). Retrieved on 2007-11-06.